LB Pharmaceuticals Inc
LBRX
$15.35
-$0.16-1.03%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -29.43M | -52.04M | -63.10M | -- | -- |
| Total Depreciation and Amortization | 240.00K | 165.50K | 91.00K | -- | -- |
| Total Amortization of Deferred Charges | 3.22M | 3.22M | 3.22M | -- | -- |
| Total Other Non-Cash Items | 1.41M | 3.36M | 3.43M | -- | -- |
| Change in Net Operating Assets | -16.87M | -5.05M | 3.31M | -- | -- |
| Cash from Operations | -41.43M | -50.35M | -53.05M | -- | -- |
| Capital Expenditure | -693.00K | -728.00K | -769.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 48.09M | 52.52M | 24.00M | -- | -- |
| Cash from Investing | 47.40M | 51.79M | 23.23M | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 20.00K | 23.00K | 23.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 0.00 | 40.00M | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -1.71M | -- | -- |
| Cash from Financing | 20.00K | 23.00K | 38.32M | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.99M | 1.47M | 8.50M | -- | -- |